Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/26/2003CA2468880A1 Tetrahydrocarbazole derivatives as ligands for g-protein coupled receptors (gpcr)
06/26/2003CA2468790A1 Chemokine mutants acting as chemokine antagonists
06/26/2003CA2468783A1 Cis-imidazolines as mdm2 inhibitors
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003CA2467780A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
06/26/2003CA2467279A1 Solubilized topoisomerase poison agents
06/26/2003CA2460806A1 Taojiks as modifiers of the beta-catenin pathway and methods of use
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321467A2 High affinity inhibitors for target validation and uses thereof
06/25/2003EP1321148A1 Cyclotetrasaccharide for augmenting "active-oxygen-eliminating-activity"
06/25/2003EP1321145A1 Antitumor agents
06/25/2003EP1321143A1 Combination of N-butyldeoxygalactonojirimycin and glycolipid degrading enzyme in therapy
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320604A2 Cripto mutant and uses thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320589A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use
06/25/2003EP1320581A1 T cell receptor transfer into a candidate effector cell or a precursor thereof
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320534A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320530A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320386A1 A novel cationic lipopolymer as biocompatible gene delivery agent
06/25/2003EP1320383A2 Photosensitisers
06/25/2003EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1320359A2 Thermogelling biodegradable aqueous polymer solution
06/25/2003EP1320300A1 Food supplement
06/25/2003EP1244650B1 Arylamine derivatives and their use as anti-telomerase agent
06/25/2003EP1200439B1 1,2-dihydro-1-oxo-parazino(1,2-a) indole derivatives
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1161436B1 Polyunsaturated fatty acid derivatives and their use in the treatment of cancer
06/25/2003EP1071704B1 Novel matrix metalloproteinase inhibitors and down-regulators
06/25/2003EP1069915B1 Hydroxylation activated drug release
06/25/2003EP1064279B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
06/25/2003EP1000008B1 Novel thyroid receptor ligands and method
06/25/2003EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies
06/25/2003EP0932411B1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
06/25/2003EP0910365B1 Growth inhibition and eradication of solid tumors using a prolactin modulator and a photosensitizer
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0802783B1 Topical preparations containing l-arginine
06/25/2003EP0727984B1 Controlled release preparation
06/25/2003EP0673372B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
06/25/2003CN1426472A Nucleic acid construct encoding processing component derived from N-terminal region of hepatitis virus ORF2, and an antigenic polypeptide
06/25/2003CN1426468A KCNB: novel potassium channel protein
06/25/2003CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1426461A Method of producing membrane vesicles
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426413A Imidazopyridine derivatives
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative
06/25/2003CN1426398A Condensed heteroaryl derivatives
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1426311A Medicament for stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and method for production thereof
06/25/2003CN1426309A Adjuvanted genetic vaccines
06/25/2003CN1426307A 蛋白质 Protein
06/25/2003CN1426305A Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract
06/25/2003CN1425667A New compound with anti-tumor function, its preparing method and use in preparing medicine for curing tumor
06/25/2003CN1425467A Method for regulating replication of nonreplication adenovirus
06/25/2003CN1425466A Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine
06/25/2003CN1425463A Reinforced lucid ganoderma capable of immune preventing and immune curing cancer and its preparing method
06/25/2003CN1425438A Medicine for curing leukemia
06/25/2003CN1425415A Medicine for curing cancer
06/25/2003CN1425381A Product of ginsenoside for curing cancer
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/25/2003CN1112207C Oral Chinese medicine liquid for treating tumor
06/25/2003CN1112205C Aloe health-care beverage product and its preparing method
06/25/2003CN1112182C Medicinal application of aquatic-sunflower lactone
06/25/2003CN1112179C Sustained release and implantation type doxorubicin medicine and method for preparing same
06/25/2003CN1112178C Sustained release and implantion type methotrexate medicine and method for preparing same
06/24/2003US6583321 4′-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/24/2003US6583319 Cyclic compounds having a cycloalkylene chain
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583290 14-methyl epothilone derivatives
06/24/2003US6583272 Protein conjugate for use in the treatment of blood disorders
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
06/24/2003US6583167 Methods and kits for treating and diagnosing leiomyomas
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583162 Chronic dermal ulcers, wound healing
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
1 ... 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 ... 2211